JOHN SICARD

Corporate Board Profile

Tech Score: 0/100

Orthofix Medical Inc.

Filing Date	Source Excerpt
2019-04-29	Mr. Sicard, 56, became a director of Orthofix in March 2018. ... John Sicard 60,000 fees earned or paid in cash, 2,900 restricted stock awards, 164,952 grant date fair value of restricted stock awards, 30,000 option awards, 505,639 grant date fair value of option awards, total 730,591.
2020-04-29	Mr. Sicard, 57, became a director of Orthofix in March 2018... The Board believes that Mr. Sicard’s extensive experience as a strategic supply chain management executive, as well as his current board membership, brings unique and valuable insight to the Board. ... The following table provides information regarding the 2019 compensation of non-employee directors. ... John Sicard 70,000 fees earned in cash, 3,431 restricted stock awards, 174,981 grant date fair value of restricted stock awards, total 244,981.

Filing Date

Source Excerpt

2019-04-29

Mr. Sicard, 56, became a director of Orthofix in March 2018. ... John Sicard 60,000 fees earned or paid in cash, 2,900 restricted stock awards, 164,952 grant date fair value of restricted stock awards, 30,000 option awards, 505,639 grant date fair value of option awards, total 730,591.

2020-04-29

Mr. Sicard, 57, became a director of Orthofix in March 2018... The Board believes that Mr. Sicard’s extensive experience as a strategic supply chain management executive, as well as his current board membership, brings unique and valuable insight to the Board. ... The following table provides information regarding the 2019 compensation of non-employee directors. ... John Sicard 70,000 fees earned in cash, 3,431 restricted stock awards, 174,981 grant date fair value of restricted stock awards, total 244,981.

Data sourced from SEC filings. Last updated: 2026-02-03